# RxEconomics

> RxEconomics LLC is a boutique health economics and outcomes research (HEOR) consultancy led by Dr. M. Christopher Roebuck, PhD, MBA — a health economist with 28+ years of experience in pharmaceutical economics, published in Health Affairs, Medical Care, and the American Economic Review. The firm combines rigorous econometric methods with generative AI to deliver results typically 3× faster than traditional consultancies. Based in Miami, FL; serving pharmaceutical manufacturers, payers, PBMs, law firms, and policy organizations nationally.

Tagline: Health Economics & Outcomes Research at AI Speed.

## Services

- [Real-World Evidence & Claims Analytics](https://www.rxeconomics.com/solutions/real-world-evidence-claims-analytics): claims-based studies using client-provided, licensed, or public-use data (MarketScan, Optum, Medicare, Medicaid MAX/TAF/SDUD, MEPS, NHIS), EHR, and registries; comparative effectiveness, adherence analysis, external control arms.
- [Health Economics & Outcomes Research (HEOR)](https://www.rxeconomics.com/solutions/health-economics-outcomes-research): economic modeling (budget impact, cost-effectiveness), value dossiers, medication adherence research, peer-reviewed real-world evidence generation.
- [AI-Powered HEOR](https://www.rxeconomics.com/solutions/ai-heor): Expert-Verified AI for HEOR — AI-accelerated evidence generation with expert verification built in, aligned with ISPOR's ELEVATE-GenAI reporting guidelines.
- [Health Policy Analysis & Market Access](https://www.rxeconomics.com/solutions/health-policy-market-access): drug pricing policy analysis (MFN, IRA, 340B), payer evidence, reimbursement strategy, HTA response.
- [Litigation Support & Expert Witness](https://www.rxeconomics.com/solutions/healthcare-economic-expert-witness): economic damages analysis, attributable-cost modeling, expert reports and testimony in healthcare litigation.

Typical timelines: a focused economic model in 4-6 weeks (vs 12-18 weeks); comprehensive real-world evidence generation in 3-4 months (vs 9-12 months).

## Key pages

- [Home](https://www.rxeconomics.com/)
- [About RxEconomics](https://www.rxeconomics.com/about)
- [Dr. M. Christopher Roebuck — professional profile](https://www.rxeconomics.com/about/m-christopher-roebuck): credentials, career, education, research record, and policy citations of the founder.
- [Solutions](https://www.rxeconomics.com/solutions): hub for the five service practices linked above.
- [Insights](https://www.rxeconomics.com/insights): analysis of AI in HEOR and drug pricing policy, including a four-part AI-in-HEOR series and MFN/TrumpRx policy analyses.
- [Publications](https://www.rxeconomics.com/publications): the full bibliography — peer-reviewed articles, reports, and issue briefs with DOI and PubMed links, ungated.
- [Contact](https://www.rxeconomics.com/contact): complimentary consultation; response within one business day.

## Author

Dr. M. Christopher Roebuck — President & CEO. Profile: https://www.rxeconomics.com/about/m-christopher-roebuck · Google Scholar: https://scholar.google.com/citations?user=9W-bItIAAAAJ · ORCID: https://orcid.org/0000-0003-4102-4925 · LinkedIn: https://www.linkedin.com/in/rxeconomics/

## Contact

contact@rxeconomics.com · +1 (410) 215-8380 · 2101 Brickell Avenue, Suite 3101, Miami, FL 33129